Michelle D Failla1, Raj G Kumar2, Andrew B Peitzman3, Yvette P Conley4, Robert E Ferrell5, Amy K Wagner6. 1. Department of Physical Medicine & Rehabilitation, University of Pittsburgh, School of Medicine, Pittsburgh PA Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA. 2. Department of Physical Medicine & Rehabilitation, University of Pittsburgh, School of Medicine, Pittsburgh PA. 3. Department of Surgery, University of Pittsburgh, School of Medicine, Pittsburgh PA. 4. Department of Health Promotion & Development, University of Pittsburgh, School of Nursing, Pittsburgh, PA. 5. Department of Human Genetics, University of Pittsburgh, School of Public Health, Pittsburgh, PA. 6. Department of Physical Medicine & Rehabilitation, University of Pittsburgh, School of Medicine, Pittsburgh PA Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA Safar Center for Resuscitation Research, University Pittsburgh, Pittsburgh, PA wagnerak@upmc.edu.
Abstract
BACKGROUND: Mortality predictions following traumatic brain injury (TBI), and our understanding of TBI pathology, may be improved by including genetic risk in addition to traditional prognostic variables. One promising target is the gene coding for brain-derived neurotrophic factor (BDNF), a ubiquitous neurotrophin important for neuronal survival and neurogenesis. OBJECTIVE: We hypothesized the addition of BDNF genetic variation would improve mortality prediction models and that BDNF Met-carriers (rs6265) and C-carriers (rs7124442) would have the highest mortality rates post-TBI. METHODS: This study examined BDNF functional single nucleotide polymorphisms rs6265 (val66met) and rs7124442 (T>C) in relation to mortality in a prospective, longitudinal cohort with severe TBI. We examined 315 individuals receiving care for a closed head injury within the University of Pittsburgh Medical Center, aged 16 to 74 years. Mortality was examined acutely (0-7 days postinjury) and postacutely (8-365 days postinjury). A gene risk score (GRS) was developed to examine both BDNF loci. Cox proportional hazards models were used to calculate hazard ratios for survivability post-TBI while controlling for covariates. RESULTS: BDNF GRS was significantly associated with acute mortality, regardless of age. Interestingly, subjects in the hypothesized no-risk allele group had the lowest survival probability. Postacutely, BDNF-GRS interacted with age such that younger participants in the no-risk group had the highest survival probability, while older participants in the hypothesized no-risk group had the lowest probability of survival. CONCLUSIONS: These data suggest complex relationships between BDNF and TBI mortality that interact with age to influence survival predictions beyond clinical variables alone. Evidence supporting dynamic, temporal balances of pro-survival/pro-apoptotic target receptors may explain injury and age-related gene associations.
BACKGROUND: Mortality predictions following traumatic brain injury (TBI), and our understanding of TBI pathology, may be improved by including genetic risk in addition to traditional prognostic variables. One promising target is the gene coding for brain-derived neurotrophic factor (BDNF), a ubiquitous neurotrophin important for neuronal survival and neurogenesis. OBJECTIVE: We hypothesized the addition of BDNF genetic variation would improve mortality prediction models and that BDNF Met-carriers (rs6265) and C-carriers (rs7124442) would have the highest mortality rates post-TBI. METHODS: This study examined BDNF functional single nucleotide polymorphisms rs6265 (val66met) and rs7124442 (T>C) in relation to mortality in a prospective, longitudinal cohort with severe TBI. We examined 315 individuals receiving care for a closed head injury within the University of Pittsburgh Medical Center, aged 16 to 74 years. Mortality was examined acutely (0-7 days postinjury) and postacutely (8-365 days postinjury). A gene risk score (GRS) was developed to examine both BDNF loci. Cox proportional hazards models were used to calculate hazard ratios for survivability post-TBI while controlling for covariates. RESULTS:BDNF GRS was significantly associated with acute mortality, regardless of age. Interestingly, subjects in the hypothesized no-risk allele group had the lowest survival probability. Postacutely, BDNF-GRS interacted with age such that younger participants in the no-risk group had the highest survival probability, while older participants in the hypothesized no-risk group had the lowest probability of survival. CONCLUSIONS: These data suggest complex relationships between BDNF and TBI mortality that interact with age to influence survival predictions beyond clinical variables alone. Evidence supporting dynamic, temporal balances of pro-survival/pro-apoptotic target receptors may explain injury and age-related gene associations.
Authors: Maithili Sashindranath; Andre Laval Samson; Catherine Eliza Downes; Peter John Crack; Andrew John Lawrence; Qiao-Xin Li; Ashley Quan Ping Ng; Nigel Charles Jones; Jessica Jade Farrugia; Eman Abdella; Jean-Dominique Vassalli; Rime Madani; Robert Lindsay Medcalf Journal: Lab Invest Date: 2011-04-25 Impact factor: 5.662
Authors: João R Gomes; João T Costa; Carlos V Melo; Federico Felizzi; Patrícia Monteiro; Maria J Pinto; Ana R Inácio; Tadeusz Wieloch; Ramiro D Almeida; Mário Grãos; Carlos B Duarte Journal: J Neurosci Date: 2012-03-28 Impact factor: 6.167
Authors: Amy K Wagner; Hülya Bayir; Dianxu Ren; Ava Puccio; Ross D Zafonte; Patrick M Kochanek Journal: J Neurotrauma Date: 2004-02 Impact factor: 5.269
Authors: Cristiane Ritter; Aline S Miranda; Vinícius Renê Giombelli; Cristiane D Tomasi; Clarissa M Comim; Antonio Lucio Teixeira; João Quevedo; Felipe Dal-Pizzol Journal: Crit Care Date: 2012-12-17 Impact factor: 9.097
Authors: Michelle D Failla; John M Myrga; Joseph H Ricker; C Edward Dixon; Yvette P Conley; Amy K Wagner Journal: J Head Trauma Rehabil Date: 2015 Nov-Dec Impact factor: 2.710
Authors: Patrick M Kochanek; Travis C Jackson; Ruchira M Jha; Robert S B Clark; David O Okonkwo; Hülya Bayır; Samuel M Poloyac; Amy K Wagner; Philip E Empey; Yvette P Conley; Michael J Bell; Anthony E Kline; Corina O Bondi; Dennis W Simon; Shaun W Carlson; Ava M Puccio; Christopher M Horvat; Alicia K Au; Jonathan Elmer; Amery Treble-Barna; Milos D Ikonomovic; Lori A Shutter; D Lansing Taylor; Andrew M Stern; Steven H Graham; Valerian E Kagan; Edwin K Jackson; Stephen R Wisniewski; C Edward Dixon Journal: J Neurotrauma Date: 2019-02-01 Impact factor: 5.269
Authors: David J Barton; Raj G Kumar; Emily H McCullough; Gary Galang; Patricia M Arenth; Sarah L Berga; Amy K Wagner Journal: J Head Trauma Rehabil Date: 2016 Jul-Aug Impact factor: 2.710
Authors: Victoria C Merritt; Alexandra L Clark; Nicole D Evangelista; Scott F Sorg; Dawn M Schiehser; Lisa Delano-Wood Journal: Clin Neuropsychol Date: 2020-03-24 Impact factor: 3.535